PHATHOM PHARMACEUTICALS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PHATHOM PHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2023-03-31 was $14.07M.
- PHATHOM PHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2022-09-30 was $24.60M.
- PHATHOM PHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2019-06-30 was $5.88M.
- PHATHOM PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2022 was $24.59M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2023-03-31 | $14.07M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $24.59M 10-K · filed 2023-02-28 | |
| 2022-09-30 | $24.60M 10-Q/A · filed 2022-11-09 | |
| 2019-06-30 | $5.88M 10-Q · filed 2019-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 |